These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 36851782)

  • 1. Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases.
    Hajjo R; Sabbah DA; Abusara OH; Kharmah R; Bardaweel S
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry strategies toward host targeting antiviral agents.
    Ji X; Li Z
    Med Res Rev; 2020 Sep; 40(5):1519-1557. PubMed ID: 32060956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2.
    Wagoner J; Herring S; Hsiang TY; Ianevski A; Biering SB; Xu S; Hoffmann M; Pöhlmann S; Gale M; Aittokallio T; Schiffer JT; White JM; Polyak SJ
    Microbiol Spectr; 2022 Oct; 10(5):e0333122. PubMed ID: 36190406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs.
    Schor S; Einav S
    DNA Cell Biol; 2018 Feb; 37(2):63-69. PubMed ID: 29148875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals.
    Chitalia VC; Munawar AH
    J Transl Med; 2020 Oct; 18(1):390. PubMed ID: 33059719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
    Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
    Front Immunol; 2019; 10():60. PubMed ID: 30761132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning techniques applied to the drug design and discovery of new antivirals: a brief look over the past decade.
    Serafim MSM; Dos Santos Júnior VS; Gertrudes JC; Maltarollo VG; Honorio KM
    Expert Opin Drug Discov; 2021 Sep; 16(9):961-975. PubMed ID: 33957833
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug Repurposing for Viral Infectious Diseases: How Far Are We?
    Mercorelli B; Palù G; Loregian A
    Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-targeting agents in the treatment of hepatitis C: a beginning and an end?
    Baugh JM; Garcia-Rivera JA; Gallay PA
    Antiviral Res; 2013 Nov; 100(2):555-61. PubMed ID: 24091203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phenomics approach for antiviral drug discovery.
    Rietdijk J; Tampere M; Pettke A; Georgiev P; Lapins M; Warpman-Berglund U; Spjuth O; Puumalainen MR; Carreras-Puigvert J
    BMC Biol; 2021 Aug; 19(1):156. PubMed ID: 34334126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finding a chink in the armor: Update, limitations, and challenges toward successful antivirals against flaviviruses.
    Komarasamy TV; Adnan NAA; James W; Balasubramaniam VR
    PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010291. PubMed ID: 35482672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex viruses in antiviral drug discovery.
    Schang LM
    Curr Pharm Des; 2006; 12(11):1357-70. PubMed ID: 16611120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?
    Ezat AA; Abduljalil JM; Elghareib AM; Samir A; Elfiky AA
    Expert Opin Drug Discov; 2023 May; 18(5):551-561. PubMed ID: 37032577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2019 Feb; 14(2):153-168. PubMed ID: 30585088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe-in-Man Broad Spectrum Antiviral Agents.
    Yao R; Ianevski A; Kainov D
    Adv Exp Med Biol; 2021; 1322():313-337. PubMed ID: 34258746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinase Inhibitors as Underexplored Antiviral Agents.
    García-Cárceles J; Caballero E; Gil C; Martínez A
    J Med Chem; 2022 Jan; 65(2):935-954. PubMed ID: 33970631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing for new, efficient, broad spectrum antivirals.
    García-Serradilla M; Risco C; Pacheco B
    Virus Res; 2019 Apr; 264():22-31. PubMed ID: 30794895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.
    Anasir MI; Ramanathan B; Poh CL
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing drugs targeting epidemic viruses.
    Namasivayam V; Palaniappan S; Vanangamudi M
    Drug Discov Today; 2022 Jul; 27(7):1874-1894. PubMed ID: 35427764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery.
    Li X; Peng T
    Front Pharmacol; 2021; 12():660710. PubMed ID: 34017257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.